Comparative efficacy of switching to natalizumab in active multiple sclerosis

Timothy Spelman, Tomas Kalincik, Annie Zhang, Fabio Pellegrini, Heinz Wiendl, Ludwig Kappos, Larisa Tsvetkova, Shibeshih Belachew, Robert Hyde, Freek Verheul, Francois Grand-Maison, Guillermo Izquierdo, Pierre Grammond, Pierre Duquette, Alessandra Lugaresi, Jeannette Lechner-Scott, Celia Oreja-Guevara, Raymond Hupperts, Thor Petersen, Michael Barnett, Maria Trojano, Helmut Butzkueven
  • Annals of Clinical and Translational Neurology, February 2015, Wiley
  • DOI: 10.1002/acn3.180
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Dr Tim Spelman, Dr Tomas Kalincik, and Alessandra Lugaresi